MedTrace Logo

G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

NCT04992455 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-08-05

No results posted yet for this study

Summary

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.

Conditions

  • Predicting Chemotherapy Related Toxicity in Elderly Patients

Interventions

OTHER

Older Patients Receiving Chemotherapy

No Intervention

Sponsors & Collaborators

  • Namik Kemal University

    lead OTHER

Principal Investigators

  • Erdoğan S Şeber, Assoc. Prof. · Namik Kemal University

  • Eyyüp Çavdar, MD · Namik Kemal University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04992455 on ClinicalTrials.gov